NO20055144L - Preparat for behandling av mikrobielle og parasittiske infeksjoner hos storfe og andre dyr. - Google Patents

Preparat for behandling av mikrobielle og parasittiske infeksjoner hos storfe og andre dyr.

Info

Publication number: NO20055144L
Authority: NO; Norway
Prior art keywords: cattle; treatment; parasitic infections; microbial; animals
Prior art date: 2003-04-03

Application number

NO20055144A

Other languages

English (en)

Norwegian (no)

Inventor

Dale E Shuster

David G Sawutz

Kanwal J Varma

Original Assignee

Schering Plough Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-04-03

Filing date

2005-11-02

Publication date

2005-11-02

2005-11-02 Application filed by Schering Plough Ltd filed Critical Schering Plough Ltd

2005-11-02 Publication of NO20055144L publication Critical patent/NO20055144L/no

Links

241000283690 Bos taurus Species 0.000 title abstract 3
208000030852 Parasitic disease Diseases 0.000 title abstract 2
241001465754 Metazoa Species 0.000 title 1
230000000813 microbial effect Effects 0.000 title 1
238000009472 formulation Methods 0.000 abstract 2
239000000203 mixture Substances 0.000 abstract 2
AYIRNRDRBQJXIF-NXEZZACHSA-N (-)-Florfenicol Chemical compound CS(=O)(=O)C1=CC=C([C@@H](O)[C@@H](CF)NC(=O)C(Cl)Cl)C=C1 AYIRNRDRBQJXIF-NXEZZACHSA-N 0.000 abstract 1
239000005660 Abamectin Substances 0.000 abstract 1
208000035473 Communicable disease Diseases 0.000 abstract 1
241000282898 Sus scrofa Species 0.000 abstract 1
239000003242 anti bacterial agent Substances 0.000 abstract 1
230000002141 anti-parasite Effects 0.000 abstract 1
239000003096 antiparasitic agent Substances 0.000 abstract 1
RRZXIRBKKLTSOM-XPNPUAGNSA-N avermectin B1a Chemical compound C1=C[C@H](C)[C@@H]([C@@H](C)CC)O[C@]11O[C@H](C\C=C(C)\[C@@H](O[C@@H]2O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](OC)C3)[C@@H](OC)C2)[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\2)O)C[C@H]4C1 RRZXIRBKKLTSOM-XPNPUAGNSA-N 0.000 abstract 1
230000003115 biocidal effect Effects 0.000 abstract 1
WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical class ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
229960003760 florfenicol Drugs 0.000 abstract 1
230000002265 prevention Effects 0.000 abstract 1
208000023504 respiratory system disease Diseases 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
- A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/655—Azo (—N=N—), diazo (=N2), azoxy (>N—O—N< or N(=O)—N<), azido (—N3) or diazoamino (—N=N—N<) compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Oil, Petroleum & Natural Gas (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Molecular Biology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Oncology (AREA)
Dermatology (AREA)
Communicable Diseases (AREA)
Tropical Medicine & Parasitology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Saccharide Compounds (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)

NO20055144A 2003-04-03 2005-11-02 Preparat for behandling av mikrobielle og parasittiske infeksjoner hos storfe og andre dyr. NO20055144L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US46012603P	2003-04-03	2003-04-03
PCT/US2004/010143 WO2004089355A2 (en)	2003-04-03	2004-04-01	Compositions for treating microbial and parasitic infections in cattle and other animals

Publications (1)

Publication Number	Publication Date
NO20055144L true NO20055144L (no)	2005-11-02

Family

ID=33159732

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20055144A NO20055144L (no)	2003-04-03	2005-11-02	Preparat for behandling av mikrobielle og parasittiske infeksjoner hos storfe og andre dyr.

Country Status (22)

Country	Link
US (1)	US20040198704A1 (es)
EP (1)	EP1608356A2 (es)
JP (1)	JP2006522147A (es)
KR (1)	KR20060021821A (es)
CN (1)	CN1767822A (es)
AR (1)	AR043824A1 (es)
AU (1)	AU2004227997A1 (es)
BR (1)	BRPI0419273A (es)
CA (1)	CA2519380A1 (es)
CL (1)	CL2004000710A1 (es)
EC (1)	ECSP056074A (es)
HK (1)	HK1080366A1 (es)
MX (1)	MXPA05010693A (es)
NO (1)	NO20055144L (es)
NZ (1)	NZ542379A (es)
PE (1)	PE20050099A1 (es)
PL (1)	PL378820A1 (es)
RU (1)	RU2359667C2 (es)
TW (1)	TW200503682A (es)
UA (1)	UA82359C2 (es)
WO (1)	WO2004089355A2 (es)
ZA (1)	ZA200507857B (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PE20050386A1 (es)	2003-05-29	2005-06-23	Schering Plough Ltd	Composiciones farmaceuticas de florfenicol
US7439268B2 (en) *	2003-07-18	2008-10-21	Idexx Laboratories	Compositions containing prodrugs of florfenicol and methods of use
GB0501220D0 (en) *	2005-01-21	2005-03-02	Norbrook Lab Ltd	Anthelmintic composition
PT1850664E (pt) *	2005-02-24	2014-03-26	Syngenta Ltd	Formulação de cápsulas
CN101600686A (zh)	2006-12-13	2009-12-09	先灵-普劳有限公司	氯霉素、甲砜霉素及其类似物的水溶性前药
US7550625B2 (en) *	2007-10-19	2009-06-23	Idexx Laboratories	Esters of florfenicol
WO2009070687A1 (en) *	2007-11-26	2009-06-04	Merial Limited	Solvent systems for pour-on formulations for combating parasites
PE20091171A1 (es) *	2007-12-14	2009-08-03	Schering Plough Ltd	Proceso para recuperar florfenicol y analogos de florfenicol
JP2011529895A (ja)	2008-07-30	2011-12-15	インターベツト・インターナシヨナル・ベー・ベー	フロルフェニコール中間体として有用なオキサゾリン保護アミノジオール化合物を調製する方法
RU2397753C1 (ru) *	2009-05-12	2010-08-27	Общество с ограниченной ответственностью "Алвис"	Композиция для лечения бактериальных инфекций у животных
KR101473979B1 (ko) *	2013-01-18	2014-12-26	한국썸벧(주)	마보플록사신을 포함하는 약제학적 조성물
RU2641962C2 (ru) *	2013-07-03	2018-01-23	С.П. Ветеринариа, С.А.	Инъецируемая ветеринарная композиция
EP3023092A1 (en) *	2014-11-20	2016-05-25	Ceva Sante Animale	Eprinomectin parenteral compositions
RU2649809C2 (ru) *	2015-03-03	2018-04-04	Общество с ограниченной ответственностью "Научно-внедренческий центр "Агроветзащита"	Жидкая гомогенная фаза для трансдермальных фармацевтических композиций
CN105079000B (zh) *	2015-09-22	2018-07-06	佛山市南海东方澳龙制药有限公司	一种组合物及其应用、制剂
CN105796488A (zh) *	2016-03-23	2016-07-27	张先碧	一种氟苯尼考溶液制剂及其制备方法
US9943387B2 (en)	2016-06-29	2018-04-17	International Business Machines Corporation	Unmanned aerial vehicle-based system for livestock parasite amelioration
JP7082445B2 (ja) *	2016-12-23	2022-06-08	インターベットインターナショナルベー．フェー．	ウシ又はブタの呼吸器疾患を治療するための化合物
KR102647267B1 (ko) *	2021-06-29	2024-03-18	대한뉴팜(주)	툴라스로마이신과 톨페남산의 복합 주사제 제제

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4199569A (en) *	1977-10-03	1980-04-22	Merck & Co., Inc.	Selective hydrogenation products of C-076 compounds and derivatives thereof
US5733566A (en) *	1990-05-15	1998-03-31	Alkermes Controlled Therapeutics Inc. Ii	Controlled release of antiparasitic agents in animals
US5082863A (en) *	1990-08-29	1992-01-21	Schering Corporation	Pharmaceutical composition of florfenicol
US5773422A (en) *	1996-01-29	1998-06-30	Komer; Gene	Avermectin formulation
US6074657A (en) *	1997-03-20	2000-06-13	Pharmacia & Upjohn Company	Administration of an injectable antibiotic in the ear of an animal
US6174540B1 (en) *	1998-09-14	2001-01-16	Merck & Co., Inc.	Long acting injectable formulations containing hydrogenated caster oil
US6340672B1 (en) *	2000-02-16	2002-01-22	Phoenix Scientific, Inc.	Parasiticidal formulation and a method of making this formulation
US6787568B1 (en) *	2000-11-27	2004-09-07	Phoenix Scientific, Inc.	Antibiotic/analgesic formulation and a method of making this formulation
WO2002088158A1 (en) *	2001-04-27	2002-11-07	Pfizer Products Inc.	Process for preparing 4'-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives
US20030068339A1 (en) *	2001-10-02	2003-04-10	Phoenix Scientific, Inc.	Veterinary florfenicol formulation that is syringeable under cold weather conditions
US6790867B2 (en) *	2002-05-20	2004-09-14	Schering-Plough Animal Health Corporation	Compositions and method for treating infection in cattle and swine
NZ520295A (en) *	2002-07-19	2005-04-29	Ashmont Holdings Ltd	Anthelmintic formulations comprising levamisole and either an avermectin or milbemycin
US6653288B1 (en) *	2002-09-30	2003-11-25	Virbac S.A.	Injectable anthelmintic compositions and methods for using same
US20040091579A1 (en) *	2002-11-13	2004-05-13	Rubicon Scientific Llc;	Extruded foodstuffs having maintenance level actives
PE20050386A1 (es) *	2003-05-29	2005-06-23	Schering Plough Ltd	Composiciones farmaceuticas de florfenicol

2004
- 2004-01-04 UA UAA200510401A patent/UA82359C2/uk unknown
- 2004-04-01 BR BRPI0419273-7A patent/BRPI0419273A/pt not_active IP Right Cessation
- 2004-04-01 PL PL378820A patent/PL378820A1/pl not_active Application Discontinuation
- 2004-04-01 KR KR1020057018476A patent/KR20060021821A/ko not_active Ceased
- 2004-04-01 EP EP04749650A patent/EP1608356A2/en not_active Withdrawn
- 2004-04-01 WO PCT/US2004/010143 patent/WO2004089355A2/en not_active Ceased
- 2004-04-01 MX MXPA05010693A patent/MXPA05010693A/es active IP Right Grant
- 2004-04-01 CN CNA2004800089541A patent/CN1767822A/zh active Pending
- 2004-04-01 PE PE2004000346A patent/PE20050099A1/es not_active Application Discontinuation
- 2004-04-01 NZ NZ542379A patent/NZ542379A/en unknown
- 2004-04-01 JP JP2006509616A patent/JP2006522147A/ja active Pending
- 2004-04-01 AR ARP040101104A patent/AR043824A1/es not_active Application Discontinuation
- 2004-04-01 CA CA002519380A patent/CA2519380A1/en not_active Abandoned
- 2004-04-01 CL CL200400710A patent/CL2004000710A1/es unknown
- 2004-04-01 AU AU2004227997A patent/AU2004227997A1/en not_active Abandoned
- 2004-04-01 HK HK06100218.0A patent/HK1080366A1/zh unknown
- 2004-04-01 RU RU2005133875/15A patent/RU2359667C2/ru not_active IP Right Cessation
- 2004-04-02 US US10/816,663 patent/US20040198704A1/en not_active Abandoned
- 2004-04-02 TW TW093109164A patent/TW200503682A/zh unknown
2005
- 2005-09-28 ZA ZA200507857A patent/ZA200507857B/xx unknown
- 2005-10-03 EC EC2005006074A patent/ECSP056074A/es unknown
- 2005-11-02 NO NO20055144A patent/NO20055144L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
NZ542379A (en)	2009-01-31
ZA200507857B (en)	2007-04-25
RU2005133875A (ru)	2006-03-20
WO2004089355A3 (en)	2005-01-20
ECSP056074A (es)	2006-03-01
TW200503682A (en)	2005-02-01
AU2004227997A1 (en)	2004-10-21
US20040198704A1 (en)	2004-10-07
BRPI0419273A (pt)	2008-07-15
CA2519380A1 (en)	2004-10-21
WO2004089355A2 (en)	2004-10-21
PL378820A1 (pl)	2006-05-29
KR20060021821A (ko)	2006-03-08
PE20050099A1 (es)	2005-02-28
RU2359667C2 (ru)	2009-06-27
JP2006522147A (ja)	2006-09-28
EP1608356A2 (en)	2005-12-28
CL2004000710A1 (es)	2005-05-27
HK1080366A1 (zh)	2006-04-28
UA82359C2 (uk)	2008-04-10
CN1767822A (zh)	2006-05-03
WO2004089355A8 (en)	2005-11-03
MXPA05010693A (es)	2005-12-12
AR043824A1 (es)	2005-08-17

Legal Events

Date	Code	Title	Description
2010-11-29	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
NO20056223L (no)	2005-12-29	Preparat til behandling av infeksjon hos kveg og svin
HK1080366A1 (zh)	2006-04-28	用於治疗在牛及其它动物中微生物和寄生虫感染的组合物及方法
BRPI0412526A (pt)	2006-09-19	composto, uso de um composto, composição farmacêutica, formulação em aerossol farmacêutica, e, método para o tratamento de um paciente humano ou animal com uma condição anti-inflamatória e/ou alérgica
UA81629C2 (ru)	2008-01-25	Применение композиции и способ лечения инфекционных заболеваний крупного рогатого скота и свиней
NO20052306L (no)	2005-07-19	Dispergerbare farmasoytiske blandinger.
BRPI0416796A (pt)	2007-03-06	compostos orgánicos
BR0313148A (pt)	2005-07-12	Formulações de liberação controlada compreendendo lamotrigina
NO20054164L (no)	2005-09-07	Immunoglobulinformulering og fremgangsmåte for fremstilling derav
CY1107480T1 (el)	2013-03-13	Χρηση aivlosin για την θepαπευτικη αγωγη και προληψη λοιμωξεων lawsonia σε χοιρους
DE602007004093D1 (de)	2010-02-11	3-substituierte n-(aryl- oder heteroaryl)pyrazoä1,5-aüpyrimidine als kinaseinhibitoren
EA200400086A1 (ru)	2004-06-24	Новые производные оксазолидинонов в качестве антибактериальных агентов
BRPI0510449A (pt)	2007-10-30	uso de formulações de meloxicam em medicina veterinária
DK1228758T3 (da)	2007-10-29	Anvendelse af sulfodehydroabietinsyre til behandling af inflammatorisk tarmsygdom
BRPI0416376A (pt)	2007-03-06	composições para a redução da colonização bacteriana e da invasão do snc e métodos de uso destes
ECSP045397A (es)	2005-01-03	6-ALQUILIDEN-PENEMS BICÍCLICOS COMO INHIBIDORES DE LAS b-LACTAMASAS
CY1114480T1 (el)	2016-10-05	Συνθεσεις που περιλαμβανουν διαχωρισμενο αγωνιστη υποδοχεα γλυκοκορτικοειδους για τη θεραπεια ή τον ελεγχο φλεγμονης προσθιου τμηματος
BRPI0407368A (pt)	2006-02-14	tratamento de doenças bacterianas dos órgãos respiratórios mediante aplicação local e fluor-quinolonas.
ECSP045405A (es)	2005-01-03	Penems 6-alquiliden heterotriciclil como inhibidores de la beta lactamasa
AU2001228513A1 (en)	2001-08-14	Stabilised pharmaceutical compositions and process for their preparation comprising an antibiotic and an expectorant
BRPI0411524A (pt)	2006-08-01	formulação farmacêutica de amoxicilina e clavulanato, uso de carboximetilcelulose de sódio, e, método de tratar infecção bacteriana em pacientes pediátricos
WO2011009771A3 (en)	2011-05-05	Immunogenic and therapeutic compositions for streptococcus suis
EA200401523A1 (ru)	2005-06-30	Способы применения и композиции для диагностики и лечения инфекционного заболевания
EP1650210A4 (en)	2007-07-18	THERAPEUTIC AGENT AGAINST HYPERKALEMIA AND BONE DISEASE
WO2004098636A3 (en)	2005-05-19	Vaccinating against infectious diseases using proteosomes
HRP20050466A2 (en)	2006-07-31	Pharmaceutical composition comprising a ltb4 antagonists and a cox-2 inhibitor or a combined cox 1/2 inhibitor